AJP - Heart BIOPAC complete lab solutions
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 292: H19-H27, 2007. First published September 8, 2006; doi:10.1152/ajpheart.00712.2006
0363-6135/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/1/H19    most recent
00712.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (32)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bolli, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bolli, R.

INVITED REVIEW

Preconditioning: a paradigm shift in the biology of myocardial ischemia

Roberto Bolli

Institute of Molecular Cardiology, University of Louisville, Louisville, Kentucky

The discovery of preconditioning (PC) has arguably been the single most important development in the field of ischemic biology in the past 20 years. The significance of this phenomenon transcends cardiovascular medicine, since it is ubiquitously observed in virtually every tissue of the body. This article reviews the pathophysiology and molecular basis of myocardial PC, with particular emphasis on the late phase of this cardioprotective adaptation. The article also discusses the exploitation of late PC for the development of novel gene therapy strategies aimed at inducing a permanently preconditioned cardiac phenotype (prophylactic cardioprotection). Besides its conceptual interest, deciphering the mechanism of late PC has considerable therapeutic reverberations, since transfer of the genes that underlie late PC would be expected to emulate the salubrious effects of this response of the heart to stress.

nitric oxide synthase; protection; cyclooxygenase-2


Address for reprint requests and other correspondence: R. Bolli, Division of Cardiology, Univ. of Louisville, 550 S. Jackson St., ACB, 3rd floor, Louisville, KY 40292 (E-mail:rbolli{at}louisville.edu)




This article has been cited by other articles:


Home page
 Circ. Res.Home page
D. H. Perlman, S. M. Bauer, H. Ashrafian, N. S. Bryan, M. F. Garcia-Saura, C. C. Lim, B. O. Fernandez, G. Infusini, M. E. McComb, C. E. Costello, et al.
Mechanistic Insights Into Nitrite-Induced Cardioprotection Using an Integrated Metabolomic/Proteomic Approach
Circ. Res., March 27, 2009; 104(6): 796 - 804.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
W. Chao
Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart
Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H1 - H12.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
K. Shinmura, K. Tamaki, and R. Bolli
Impact of 6-mo caloric restriction on myocardial ischemic tolerance: possible involvement of nitric oxide-dependent increase in nuclear Sirt1
Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2348 - H2355.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
C.-H. Chen, G. R. Budas, E. N. Churchill, M.-H. Disatnik, T. D. Hurley, and D. Mochly-Rosen
Activation of Aldehyde Dehydrogenase-2 Reduces Ischemic Damage to the Heart
Science, September 12, 2008; 321(5895): 1493 - 1495.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
P. La Padula, J. Bustamante, A. Czerniczyniec, and L. E. Costa
Time course of regression of the protection conferred by simulated high altitude to rat myocardium: correlation with mtNOS
J Appl Physiol, September 1, 2008; 105(3): 951 - 957.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
B. Zhong and D. H. Wang
N-oleoyldopamine, a novel endogenous capsaicin-like lipid, protects the heart against ischemia-reperfusion injury via activation of TRPV1
Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H728 - H735.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
M. Avkiran, A. J. Rowland, F. Cuello, and R. S. Haworth
Protein Kinase D in the Cardiovascular System: Emerging Roles in Health and Disease
Circ. Res., February 1, 2008; 102(2): 157 - 163.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
M. A. Burke, R. K. Mutharasan, and H. Ardehali
The Sulfonylurea Receptor, an Atypical ATP-Binding Cassette Protein, and Its Regulation of the KATP Channel
Circ. Res., February 1, 2008; 102(2): 164 - 176.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
A. Jahangir, S. Sagar, and A. Terzic
Aging and cardioprotection
J Appl Physiol, December 1, 2007; 103(6): 2120 - 2128.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
D. A. Brown and R. L. Moore
Perspectives in innate and acquired cardioprotection: cardioprotection acquired through exercise
J Appl Physiol, November 1, 2007; 103(5): 1894 - 1899.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
A. Terzic, R. L. Moore, and S. A. Waldman
Acquired and innate cardioprotection
J Appl Physiol, October 1, 2007; 103(4): 1436 - 1437.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
H. Sato, R. Bolli, G. D. Rokosh, Q. Bi, S. Dai, G. Shirk, and X.-L. Tang
The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2557 - H2564.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.